CXCR6 and chronic obstructive pulmonary disease: Therefore, we investigated CXCR6 expression on different immune players in patients with GOLD 1 and in subjects at risk of developing COPD, and explored its potential as an early diagnostic tool and/or strategy for therapeutic intervention.